Drugs (Pharmaceuticals)MelanomasModerna IncRNA (Ribonucleic Acid)Skin CancerVaccination and Immunization

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Drugs (Pharmaceuticals) category. Published on August 19, 2026 • Originally reported by Carolyn Y. Johnson. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com

SUPPORT OMEGAZEPRIME

Help us keep delivering breaking news and world updates.

PayPalShop OMEGAZEPIX